Unaudited Condensed Consolidated Statements of Changes in Equity - USD ($)	Common Stock		Paid-in Capital	Accumulated Deficits	Non- Controlling Interests	Total
Balance at Dec. 31, 2022	$ 26,500		$ 21,372,100	$ (13,420,400)	$ (1,016,300)	$ 6,961,900
Balance (in Shares) at Dec. 31, 2022	26,484,055
Cumulative-effect adjustment of opening balance due to adoption of fair value measurement of digital assets				30,600		30,600
Issuance of common stocks pursuant to private placement	$ 5,100		6,533,900			6,539,000
Issuance of common stocks pursuant to private placement (in Shares)	5,079,999
Net loss				(1,089,500)	(147,400)	(1,236,900)
Balance at Mar. 31, 2023	$ 31,600		27,906,000	(14,479,300)	(1,163,700)	12,294,600
Balance (in Shares) at Mar. 31, 2023	31,564,054
Balance at Dec. 31, 2022	$ 26,500		21,372,100	(13,420,400)	(1,016,300)	6,961,900
Balance (in Shares) at Dec. 31, 2022	26,484,055
Net loss						(2,808,000)
Balance at Jun. 30, 2023	$ 31,800		28,114,600	(15,806,800)	(1,318,400)	11,021,200
Balance (in Shares) at Jun. 30, 2023	31,724,631
Balance at Mar. 31, 2023	$ 31,600		27,906,000	(14,479,300)	(1,163,700)	12,294,600
Balance (in Shares) at Mar. 31, 2023	31,564,054
Issuance of common stocks to a service provider	$ 200		208,600			208,800
Issuance of common stocks to a service provider (in Shares)	160,577
Capital injection from non-controlling shareholder					88,900	88,900
Net loss				(1,327,500)	(243,600)	(1,571,100)
Balance at Jun. 30, 2023	$ 31,800		28,114,600	(15,806,800)	(1,318,400)	11,021,200
Balance (in Shares) at Jun. 30, 2023	31,724,631
Balance at Dec. 31, 2023	$ 31,800		27,822,200	(17,454,200)		$ 10,399,800
Balance (in Shares) at Dec. 31, 2023	31,724,631					31,724,631
Issuance of common stocks to certain investors in a private placement	$ 2,500		3,732,500			$ 3,735,000
Issuance of common stocks to certain investors in a private placement (in Shares)	2,490,000
Issuance of common stocks to an underwriter	$ 100		(100)
Issuance of common stocks to an underwriter (in Shares)	124,000
Issuance of common stocks to acquire a subsidiary	$ 1,500		2,263,500		1,510,000	3,775,000
Issuance of common stocks to acquire a subsidiary (in Shares)	1,500,000
Share-based compensation to employees	$ 100		361,000			361,100
Share-based compensation to employees (in Shares)	102,000
Net loss				(866,800)	(1,068,900)	(1,935,700)
Balance at Mar. 31, 2024	$ 36,000		34,179,100	(18,321,000)	441,100	16,335,200
Balance (in Shares) at Mar. 31, 2024	35,940,631
Balance at Dec. 31, 2023	$ 31,800		27,822,200	(17,454,200)		$ 10,399,800
Balance (in Shares) at Dec. 31, 2023	31,724,631					31,724,631
Net loss						$ (5,508,300)
Balance at Jun. 30, 2024	$ 38,200		38,699,200	(21,724,500)	272,000	$ 17,284,900
Balance (in Shares) at Jun. 30, 2024	38,123,566					38,123,566
Balance at Mar. 31, 2024	$ 36,000		34,179,100	(18,321,000)	441,100	$ 16,335,200
Balance (in Shares) at Mar. 31, 2024	35,940,631
Issuance of common stocks to certain investors in a private placement	$ 1,700		3,698,300			3,700,000
Issuance of common stocks to certain investors in a private placement (in Shares)	1,681,817
Share-based compensation to non-employees		[1]	120,000			120,000
Share-based compensation to non-employees (in Shares)	57,077
Issuance of common stocks to an underwriter	$ 100		(100)
Issuance of common stocks to an underwriter (in Shares)	84,091
Share-based compensation to employees	$ 400		701,900			702,300
Share-based compensation to employees (in Shares)	359,950
Net loss				(3,403,500)	(169,100)	(3,572,600)
Balance at Jun. 30, 2024	$ 38,200		$ 38,699,200	$ (21,724,500)	$ 272,000	$ 17,284,900
Balance (in Shares) at Jun. 30, 2024	38,123,566					38,123,566

[1] The amount of common stock issued for share-based compensation to non-employees was below 100.